Pages that link to "Q124744492"
Jump to navigation
Jump to search
The following pages link to Andrew G. Bostom (Q124744492):
Displaying 50 items.
- Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients (Q31790360) (← links)
- Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients (Q31906299) (← links)
- Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey (Q32063031) (← links)
- Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial (Q33770086) (← links)
- BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial (Q33814858) (← links)
- Effect of niacin on FGF23 concentration in chronic kidney disease (Q33914268) (← links)
- Determinants of plasma total homocysteine levels in Korean chronic renal transplant recipients. (Q34078757) (← links)
- Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine. (Q34315563) (← links)
- The kidney and homocysteine metabolism. (Q34373170) (← links)
- Treatment of hyperhomocysteinemia in end-stage renal disease. (Q34384739) (← links)
- Hyperhomocysteinemia in renal transplant recipients (Q34740537) (← links)
- Adiposity patterns and the risk for ESRD in postmenopausal women (Q35051169) (← links)
- Inadequacy of cardiovascular risk factor management in chronic kidney transplantation - evidence from the FAVORIT study (Q35297670) (← links)
- Safety events in kidney transplant recipients: results from the folic Acid for vascular outcome reduction in transplant trial (Q35747445) (← links)
- Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial (Q36953576) (← links)
- Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (Q37193413) (← links)
- More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients (Q37522572) (← links)
- Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort (Q38745657) (← links)
- Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial (Q38777914) (← links)
- C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy (Q40405832) (← links)
- Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial (Q40869549) (← links)
- B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients (Q40890897) (← links)
- Comparison of plasma clearance of iodixanol during versus after angiography (Q42795468) (← links)
- Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour (Q43604731) (← links)
- Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency (Q43614876) (← links)
- The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine (Q43631868) (← links)
- Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour (Q43674164) (← links)
- Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate (Q43786576) (← links)
- Homocysteine and arteriosclerosis: subclinical and clinical disease associations (Q43818890) (← links)
- Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis (Q43830015) (← links)
- Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour (Q43909357) (← links)
- Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy (Q44195332) (← links)
- Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid (Q44213047) (← links)
- Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. (Q44249445) (← links)
- The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study (Q44293270) (← links)
- Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study (Q44491561) (← links)
- Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy (Q44716963) (← links)
- Hypothesis: Potential Utility of Serum and Urine Uromodulin Measurement in Kidney Transplant Recipients? (Q45686180) (← links)
- The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD. (Q45976194) (← links)
- Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy (Q46703314) (← links)
- Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk (Q50300583) (← links)
- Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine. (Q50847733) (← links)
- Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial (Q50916792) (← links)
- Excess Prevalence of Fasting and Postmethionine-Loading Hyperhomocysteinemia in Stable Renal Transplant Recipients (Q50927274) (← links)
- High Homocysteine Levels Are Independently Related to Isolated Systolic Hypertension in Older Adults (Q50931240) (← links)
- Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study (Q51006205) (← links)
- Relationship between plasma homocysteine, vitamin status and extracranial carotid-artery stenosis in the Framingham Study population (Q51031610) (← links)
- Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort (Q51550499) (← links)
- Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients (Q51559491) (← links)
- Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine (Q51561223) (← links)